Corrigendum re “21 – Urine exosomal miRNA profiles implicate the key role of TP53 in bladder cancer development” [Eur Urol Open Sci 2022;40(Suppl 1):S31–2]
Main Authors: | E. Bitina-Barlote, J. Plonis, J.K. Vasiļonoks, E. Vjaters, J. Gardovskis, Z. Daneberga, E. Miklaševičs, M. Nakazawa-Miklaševiča |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168322008916 |
Similar Items
-
The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population
by: Plonis J, et al.
Published: (2015-12-01) -
Re: Manolis Pratsinis, Christian Fankhauser, Katerina Pratsinis, et al. Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses. Eur Urol Open Sci 2022;40:16–18
by: Julian Chavarriaga, et al.
Published: (2022-11-01) -
Corrigendum to “Rectal Perforation During Pelvic Surgery” [Eur Urol Open Sci 44 (2022) 54–59]
by: Bernardo Rocco, et al.
Published: (2023-03-01) -
Erratum to “The 15th European Multidisciplinary Congress on Urological Cancers” [Eur. Urol. Open Sci. 57 (2023) Supplement 1]
Published: (2024-01-01) -
Corrigendum re “Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?” [Eur Urol Open Sci 2020;22:9–16]
by: Sean Mahase, et al.
Published: (2022-10-01)